Iclusig
Ended Awarded Last action
- Contract number
- 36C26023F0026
- Awardee
-
Takeda Pharmaceuticals America, Inc. UEI ENNFDLWFC6L1 Part of Takeda Pharmaceutical Company LIMITED
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $76,712
Award facts
- Contract value 100% obligated
- $76,712.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Cambridge, MA 02139, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$82,789 | |
| Original award | $159,502 |
About this award
This delivery order, awarded by the Department of Veterans Affairs Veterans Health Administration to Takeda Pharmaceuticals America, Inc., is for the provision of the oncology medication ICLUSIG (ponatinib) with a potential value of $76,712.42. The contract utilizes Takeda's multiple award Federal Supply Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB), with a firm fixed price and period of performance through September 2023. No set-aside designation was applied. Takeda Pharmaceuticals America, a subsidiary of Takeda Pharmaceutical Company Limited, will supply the medication to support cancer treatment services provided by VA medical centers under Veterans Integrated Service Network 20 in the New England region. Additionally, Takeda holds an active blanket purchase agreement valued at over $13 million with the VA National Acquisition Center to provide ICLUSIG through October 2024, enabling efficient procurement of specialty pharmaceuticals for veterans across various VA Networks.
Quick answers
Who was awarded contract 36C26023F0026?
36C26023F0026 was awarded to Takeda Pharmaceuticals America, Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on October 1, 2022.
How much is contract 36C26023F0026 worth?
The government has obligated $76,712 on 36C26023F0026.
Is contract 36C26023F0026 an order under another contract?
Yes. 36C26023F0026 is a delivery order under 36F79718D0586, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26023F0026 competed?
The extent of competition for 36C26023F0026 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award